Head and neck cancers include HPV-associated oropharynx cancers which carry a favorable prognosis, as well as higher-risk cancers that have poor outcomes after standard treatment. Multidisciplinary management of these cancers depends on disease location and stage, as well patient health status and preferences.
Join Jonathan D. Schoenfeld, MD, MPH, Dana Farber Institute, for a review of cutting-edge treatment options for head and neck cancer, and innovative strategies to decrease treatment-associated toxicity for patients with HPV-associated cancers.
3660 on the Rise
3660 Waialae Avenue
Honolulu, HI 96816
Registration for those employed by a pharmaceutical/device manufacturer, consulting, or technology company is on a limited basis. For information, please contact our Corporate Relations Department.
For questions or assistance with your registration, please email our Meetings Department or call 301.984.9496, ext. 200.
The Kahala Hotel & Resort
5000 Kahala Avenue
Honolulu, HI 96816
The HSCO 2022 Annual Conference is a unique opportunity to innovate with like-minded cancer care professionals and gain effective strategies that will elevate your delivery of patient-centered care. Our experts will provide fresh perspectives and novel solutions for treating a range of cancer types, while dedicated networking breaks offer valuable time to make new contacts and explore advances in the cancer treatment pipeline from industry supporters.
Please note there is no room block associated with this conference. If you would like to make a reservation, please contact the hotel directly.
Conference attendees have access to a discounted parking rate of $9 per day at the hotel garage. This fee must be pre-paid prior to exiting the garage.
Please check back for registration—coming soon!
This educational activity will award continuing education contact hours for physicians and nurses.